PRESS RELEASES

Year
May 08 | 2025
RAPT Therapeutics Reports First Quarter 2025 Financial Results
April 15 | 2025
RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development
March 07 | 2025
RAPT Therapeutics to Participate in Upcoming Investor Conferences
March 06 | 2025
RAPT Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
January 09 | 2025
RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 06 | 2025
RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company’s Board of Directors
December 23 | 2024
RAPT Therapeutics Announces $150 Million Private Placement
December 23 | 2024
RAPT Therapeutics Announces $150 Million Private Placement
December 23 | 2024
RAPT Therapeutics and Shanghai Jemincare Pharmaceutical Announce Exclusive License Agreement for Novel Long-Acting anti-IgE Antibody
November 12 | 2024
RAPT Therapeutics Reports Third Quarter 2024 Financial Results